Peter Lin MD, CCFP
Director, Primary Care Initiatives, Canadian Heart Research Centre, North York, OntarioDr. Peter Lin, a primary care physician, is the Director of Primary Care Initiatives at the Canadian Heart Research Centre and has two busy family medicine practices in Toronto. For 7 years, he served as the medical director at the University of Toronto Scarborough Health & Wellness Centre. In 2011, he received a teaching award from the College of Family Physicians of Canada.
Dr. Lin has worked with KDIGO (Kidney Disease│Improving Global Outcomes) in an effort to help enhance care for patients with chronic kidney disease. He has been a contributing author to the Canadian Diabetes Guidelines and has served on the editorial board of Pri-Med Institute, which provides education for physicians.
Dr. Lin maintains an active lecture schedule, reflecting his varied medical interests, continuing his focus on bridging the chasm between research and clinical practice.
Disclosures
- Consultant (continuing medical education programs): AstraZeneca; Boehringer Ingelheim; Bayer; Eli Lilly; Amgen; Janssen; Merck; Pfizer; Sanofi; Abbott; HLS Therapeutics
Recent Contributions to PracticeUpdate:
- Genetic Risk, Coronary Heart Disease Events, and the Clinical Benefit of Statin Therapy
- Accelerated Diagnostic Protocol Using High-Sensitivity Cardiac Troponin T in Patients With Acute Chest Pain
- NSAID Use and Antithrombotic Therapy After Myocardial Infarction
- Combination Antihypertensives and Mortality in Older Nursing Home Residents
- Secondary Prevention After Coronary Artery Bypass Graft Surgery
- Blood Pressure Lowering in Type 2 Diabetes
- Risk After Hospitalization for Heart Failure, Acute MI, or Pneumonia
- Trimethoprim–Sulfamethoxazole With Spironolactone Increases Risk for Sudden Death
- Obesity-Related Risk for Sudden Cardiac Death in the Atherosclerosis Risk in Communities Study
- Diagnostic Testing Strategies in Emergency Department Patients With Chest Pain